Medibank (ASX:MPL) share price shrugs off further questions over profit paybacks

The health insurer's shares hit a 52-week high today…

| More on:
A telehealth doctor at her desk.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price hit a 52-week high today. This comes despite calls for the government to provide greater oversight of how health funds return COVID-19 savings to members.

At the time of writing, Medibank shares are up 0.42% from yesterday's close, currently swapping hands at $3.56.

Let's take a look at what may be impacting the health insurer's shares today.

What's happening at Medibank?

In early trading today, the Medibank share price surged to $3.74, a 52-week high, before retreating to its current level.

Investors appear to be unphased by calls for more government oversight on health insurance payouts to members. The pandemic fuelled a rise in net profits in the private health insurance sector of $1.8 billion last year.

In late December, Medibank returned $135 million in COVID-19 net claims savings to customers by holding off its premium increase for five months.

However, The Australian reported Private Hospitals Association chief executive Michael Roff questioned the transparency of how funds returned COVID-­related savings. He commented:

There needs to be some formal government monitoring of health fund balance sheets to determine how much money they're collecting that they thought they'd pay out – and how do we actually ensure that that gets back to members.

To date, there's been no process and it's been less than transparent.

The Medibank share price gained 11% throughout the course of 2021, despite the uncertainty caused by the pandemic.

As my Foolish colleague Aaron reported yesterday, the company recently released its calendar for the 2022 financial year.

Medibank is expected to reveal its half-year results for FY22 on 25 February.

Share price snap shot

The Medibank share price has gained almost 20% in the past year.

Shares in Medibank are up around 6% in the past week, while they are up more than 5% in the past month.

The company has a market capitalisation of about $9.8 billion based on the current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Ozempic maker Novo Nordisk plunges 22%. What could this mean for Resmed shares?

Novo Nordisk just lost $100 billion in market value.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 11% today

Let's see why investors are bidding this stock higher on Wednesday.

Read more »

stockmarket graphic in background with man looking at stockmarket on phone
Healthcare Shares

CSL shares are a buy – UBS

This expert is optimistic on what the business can achieve despite headwinds.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Broker says this ASX 200 biotech stock is a top buy

Let's see what Bell Potter is saying about this biotech.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why CSL shares are a buy today despite the looming Trump tariffs

A leading expert believes CSL shares are still trading for a bargain today. Here's why.

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Healthcare Shares

Why did the Telix share price just crash 16%?

Investors are sending the Telix share price plunging today. But why?

Read more »

Broker analysing the share price.
Healthcare Shares

Expert: 2 ASX healthcare stocks to avoid before reporting season

Not all healthcare stocks are created equal.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Should I buy Pro Medicus or CSL shares ahead of earnings season?

The ASX healthcare sector may be currently undervalued.

Read more »